Regional Health Properties, Inc RHE
We take great care to ensure that the data presented and summarized in this overview for REGIONAL HEALTH PROPERTIES, INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in RHE
Top Purchases
Top Sells
About RHE
Regional Health Properties, Inc., through its subsidiaries, operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. Its business principally consists of leasing and subleasing such facilities to third-party tenants, which operate the facilities. The company's facilities provide a range of healthcare services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for long-term and short-stay patients and residents. As of December 31, 2021, it owned, leased, or managed 24 facilities primarily in the Southeastern United States of America. The company was incorporated in 1991 and is headquartered in Suwanee, Georgia.
Insider Transactions at RHE
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 29
2025
|
Gene E Burleson Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+50.0%
|
$5,000
$1.99 P/Share
|
|
Aug 20
2025
|
Paul Jason O'Sullivan Senior Vice President |
BUY
Open market or private purchase
|
Indirect |
3,800
+10.19%
|
$3,800
$1.8 P/Share
|
|
Aug 19
2025
|
Paul Jason O'Sullivan Senior Vice President |
BUY
Open market or private purchase
|
Indirect |
5,600
+15.86%
|
$5,600
$1.92 P/Share
|
|
Aug 18
2025
|
Paul Jason O'Sullivan Senior Vice President |
BUY
Open market or private purchase
|
Indirect |
10,600
+30.55%
|
$10,600
$1.85 P/Share
|
|
Aug 14
2025
|
Gene E Burleson Director |
BUY
Grant, award, or other acquisition
|
Indirect |
12,029
+50.0%
|
-
|
|
Aug 14
2025
|
Gene E Burleson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,871
+50.0%
|
-
|
|
Aug 14
2025
|
Gene E Burleson Director |
BUY
Grant, award, or other acquisition
|
Indirect |
13,628
+50.0%
|
-
|
|
Aug 14
2025
|
Gene E Burleson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,253
+50.0%
|
-
|
|
Aug 14
2025
|
Mark J Stockslager CFO |
BUY
Grant, award, or other acquisition
|
Direct |
21,610
+50.0%
|
-
|
|
Aug 14
2025
|
Mark J Stockslager CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,484
+50.0%
|
-
|
|
Aug 14
2025
|
Robert M Thornton Jr EVP - Corporate Strategy |
BUY
Grant, award, or other acquisition
|
Indirect |
111,912
+50.0%
|
-
|
|
Aug 14
2025
|
Robert M Thornton Jr EVP - Corporate Strategy |
BUY
Grant, award, or other acquisition
|
Indirect |
126,796
+50.0%
|
-
|
|
Aug 14
2025
|
Robert M Thornton Jr EVP - Corporate Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Aug 14
2025
|
Steven J Baileys Director |
BUY
Grant, award, or other acquisition
|
Indirect |
56,320
+50.0%
|
-
|
|
Aug 14
2025
|
Steven J Baileys Director |
BUY
Grant, award, or other acquisition
|
Direct |
110,248
+50.0%
|
-
|
|
Aug 14
2025
|
Steven J Baileys Director |
BUY
Grant, award, or other acquisition
|
Indirect |
63,810
+50.0%
|
-
|
|
Aug 14
2025
|
Steven J Baileys Director |
BUY
Grant, award, or other acquisition
|
Direct |
124,911
+50.0%
|
-
|
|
Jun 20
2025
|
Brent Morrison CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+24.71%
|
-
|
|
Jun 20
2025
|
Brent Morrison CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
48,000
+16.66%
|
$96,000
$2.68 P/Share
|
|
Jun 19
2024
|
Brent Morrison CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+22.72%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 837K shares |
|---|---|
| Open market or private purchase | 25K shares |
| Exercise of conversion of derivative security | 48K shares |